# 510(k) Summary for

# Berichrom ™ Heparin LMW Calibrator Berichrom ™ Heparin LMW Control 1 Berichrom ™ Heparin LMW Control 2

This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requrements of SMDA 1990 and 21 CFR 807 92 The assged  e

A Manufacturer's Name, Address, Contact Information, and Date of Preparation

# 1 Manufacturer

Siemens Healthcare Diagnostics Products GmbH   
Emil-von-Behring Str 76   
35041 Marburg, Germany

2 Contact Information

Siemens Healthcare Diagnostics Inc   
500 GBC Drive   
Newark, Delaware 19702   
Attention Janet Fose, Regulatory Affairs Specialist   
Telephone 302-631-8826, Fax 302-631-6299

3 Preparation Date October 24, 2008

# B Name of Device(s)

Berchrom Heparin LMW Calibrator

Berichrom Heparin LMW Control 1

Berchrom Heparin LMW Control 2

Stemens Healthcare Diagnosbcs Inc 510(k) Notufication Benchrom™" Hepann LMW Calibrator Benchrom™" Hepann LMW Control 1 Benchrom ™" Hepann LMW Control 2

C Regulatory Information.

# 1 CFR Section(s) 864 5425 - MULTIPURPOSE SYSTEM FOR IN VITRO COAGULATION STUDIES

2 Classification(s) Class II

3 Classification Panel(s) Hematology (81)

4 Product Code(s) JPA, GIZ, GGC

D Predicate Device(s)

Calibration Plasma LMW Heparin  K030964

Control Plasma LMW Heparin - K030965

E Device Description(s)

Berchrom Heparn LMW Calibrator

Berchrom Heparin LMW Calibrator is a lyophilized product containing low molecular weight (LMW) heparin from porcine intestine and buffered human plasma Each package contains 6 vials, each vial requires reconstitution with $\bf { 1 0 m L }$ distilled or deionized water

# Berchrom Heparin LMW Control 1

Berichrom Heparin LMW Control 1 is a lyophilized, low level, assayed control contaming low molecular weight (LMW) heparin from porcine intestine and buffered human plasma Each package contains 6 vials, each vial requires reconstitution with $1 \ 0 \ \mathrm { m L }$ distilled or deionized water

# Benchrom Heparin LMW Control 2

Berchrom Heparin LMW Control 2 is a lyophlized, high level, assayed control containing low molecular weight (LMW) heparin from porcine intestine and buffered hurman plasma Each package contains 6 vials, each vial requres reconstitution with $1 0 \mathrm { m L }$ distilled or deionized water

F Device Intended Uses

Berichrom Heparn LMW Calibrator

For the calbration of the Benchrom Heparin assay for measurement of low molecular weight (LMW) heparn

Berchrom Heparin LMW Control 1

For use as a low level assayed control for the quantitative measurement of low molecular weight (LMW) heparin with the Benchrom Heparin assay

# Siemens Healthcare Diagnostics Inc 510(k) Notification Benchrom™" Hepann LMW Calibrator Benchrom™" Hepann LMW Control 1 Benchrom ™ Hepann LMW Control 2

# Berichrom Heparin LMW Control 2

For use as a high level assayed control for the quantitative measurement of low molecular weight (LMW) heparin with the Berichrom Heparin assay

# G Substantial Equivalence Information

The Berichrom Heparin LMW Calbrator, lke the Calibration Plasma LMW Heparin, 1s intended for the calibration of low molecular weight (LMW) heparin Both the proposed device and the predicate also share simlanties in form, matrix and traceability

The Berchrom Heparin LMW Control 1 and Benchrom Heparin LMW Control 2 are substantially equivalent to Control Plasma LMW Heparin The Berichrom Heparin LMW Control 1 and Benchrom Heparin LMW Control 2 like, the Control Plasma LMW Heparin are assayed quality control materals and are intended for the measurement of LMW heparin in the low and high concentration range, respectively Both the proposed devices and the predicate also share similarities in form, matrix and traceability

# H Conclusion

Based on the information provided, the proposed devices, the proposed devices are substantially equivalent to their respective predicate devices

Siemens Healthcare Diagnostics, Inc   
c/o Ms Janet M Fose   
Regulatory Affairs Specialist   
500 GBC Drive, M/S 514   
PO Box 6101   
Newark, DE 19714

Re k083159 Trade/Device Name Berichrom Heparin LMW Calibrator Berichrom Heparin LMW Control 1 Berichrom Heparin LMW Control 2 Regulation Number 21 CFR 864 5425 Regulation Name Multpurpose System for In Vitro Coagulation Studes Regulatory Class Class II Product Code JPA, GGC, GIZ Dated October 24, 2008 Received October 27, 2008

Dear Ms Fose

We have reviewed your Section $5 1 0 ( \mathbf { k } )$ premarket notification of ntent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated n the enclosure) to legally marketed predicate devices marketed n nterstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetc Act (Act) that do not requre approval of a premarket approval application (PMA) You may, therefore, market the device, subject to the general controls provisons of the Act The general controls provisions of the Act nclude requrements for annual registration, listing of devices, good manufacturing practice, labeling, and prohbitions against musbranding and adulteration

r ec vthass SlA)t t oe FealReguo F r 0 Ion F publish further announcements concerning your device in the Federal Register

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determunation that your device comples with other requirements of the Act or any Federal statutes and regulations adminstered by other Federal agencies You must comply with al the Act's reqrements, includng, but not lmte t regstraon and lstng (21 CFR Part 807), labelng (21 CFR Parts 801 and 809), and good manufacur pract requreents as st frth in the quality systems (QS) regulation (21 CFR Part 820Ths letter will alow you to begin

marketing your device as descrbed in your Section $5 1 0 ( \mathbf k )$ premarket notification The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market

If you desire specific advice for your device on our labeling regulaton (21 CFR Part 801), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (240) 276-0450 Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807 97) For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (240) 276-3474 For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at (240) 276-3464 You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http //www fda gov/cdrh/industry/support/index html

Sincerely yours,

mana In chan

Maria M Chan, Ph D   
Acting Division Director   
Division of Immunology and Hematology Devices   
Office of In Vitro Diagnostic Device Evaluation   
and Safety   
Center for Devices and Radological Health

Enclosure

# Indications for Use

510(k) Number (if known): K0 83159

Device Name: Berichrom Heparn LMW Calibrator

Indications for Use:   
Berichrom Heparin LMW Calibrator is an in vitro diagnostic product used for the calibration of the Berichrom Heparin assay for measurement of low molecular weight (LMW) heparin

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED) Cnure CRH, Of EaDE Huphine Dut 50-0 Office Of in Vitro nostic Devic Evaluation and Saiety K083159

# Indications for Use

510(k) Number (if known): Kof3/59

Device Name. Benchrom Heparin LMW Control 1

Indications for Use'   
Berichrom Heparin LMW Control 1 is an assayed, low level, quality control   
matenal for assessment of precision and analytical bias in the quantitative   
determination of low molecular weight (LMW) heparin with the Berichrom Heparin   
assay

CncucCRH, ODvaonDE Jaugphini Gautalor fceof5emD alyeyon p 5,

# Indications for Use

510(k) Number (if known): K083/59

Device Name: Benichrom Heparin LMW Control 2

Indications for Use:   
Berchrom Heparin LMW Control 2 is an assayed, high level, quality control   
matenial for assessment of precision and analytical bias in the quantitative   
determination of low molecular weight (LMW) heparin with the Berchrom Heparin   
assay

# Concurrence of CDRH, Office of Device Evaluation (ODE)